Becton Dickinson (BDX) rose 2.4% in premarket trading as reports surface of potential separation of its $30 billion life ...

Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $247.61 which represents a slight increase of $0.01 or 0.00% from the prior close of $247.6. The stock opened at $248.13 and ...

So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Becton Dickinson (NYSE:BDX). Even if this company is fairly valued by the ...

Mather Group LLC. lowered its stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by 3.3% during the 4th quarter, according to its most recent filing with the SEC. The firm owned ...

The continued solid uptake of BD's products is expected to have driven fiscal first-quarter revenues despite transitory ...

CarsonAllaria Wealth Management Ltd. bought a new stake in Becton, Dickinson and Company (NYSE:BDX – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & ...

Shares of Becton Dickinson and Co (NYSE:BDX) climbed 3.3% following news that activist investor Starboard Value has acquired ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Becton Dickinson (BDX – Research Report), Idexx Laboratories ...

Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to 30% ...

Starboard Value has taken a stake in Becton Dickinson (BDX) and is pushing the medical technology company to sell its life sciences division, ...

Becton Dickinson & Co. closed 3.80% short of its 52-week high of $251.99, which the company reached on February 3rd.

Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $249.08 which represents a slight increase of $0.38 or 0.15% from the prior close of $248.7. The stock opened at $248.68 and ...